Details.
Consultant-led monitoring after or during cancer treatment using circulating tumour DNA and circulating tumour cell analysis. Includes blood sample collection at a central London clinic or at home anywhere in the UK, advanced liquid biopsy analysis, a detailed results review via video consultation, a written report, and guidance on next steps. Recommended every 3-6 months for ongoing surveillance.
